Pharmacists in Osceola, AR Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Madelyn Dancy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2720 W Keiser Ave, Osceola, AR 72370 Phone: 870-563-6633 |
Linda Childers Wright Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2720 W Keiser Ave, Osceola, AR 72370 Phone: 870-563-6633 Fax: 870-563-8185 |
Dr. Sarah Wright Robinson, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 850 W Keiser Ave, Osceola, AR 72370 Phone: 870-563-6516 Fax: 870-563-8156 |
 Aaron Baker Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 850 W Keiser Ave, Osceola, AR 72370 Phone: 870-563-6516 Fax: 870-563-8516 |
Dr. Stephanie S Rapert, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Hale Ave, Osceola, AR 72370 Phone: 870-563-2618 Fax: 870-563-2036 |
Emily Jayne Lugar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2720 W Keiser Ave, Osceola, AR 72370 Phone: 870-563-6633 |
Jonathan Followell Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2720 W Keiser Ave, Osceola, AR 72370 Phone: 870-563-6633 Fax: 878-563-8185 |
News Archive
SLU SNMA students receive Leadership in Institutional Diversity Award
A group of 40 students are part of Saint Louis University's Student National Medical Association chapter (SNMA), who are striving to reduce health disparities locally. This year, they received the Leadership in Institutional Diversity Award, a recognition given to a university for serving as an outstanding example of leadership and innovation in promoting and maintaining institutional diversity.
Vaginal progesterone decreases preterm birth, infant mortality in twin gestations with short cervix
Treatment with vaginal progesterone reduced the risk of preterm birth, neonatal complications and death in pregnant women with twins and who have a short cervix— a risk factor for preterm birth— according to a meta-analysis of individual patient data by researchers at the National Institutes of Health, the Wayne State University School of Medicine, the Detroit Medical Center, and other institutions in the United States and abroad.
siRNA delivery into human T cells and primary cells with carbon-nanotube transporters
Short pieces of RNA, known as small interfering RNA (siRNA), have the potential to become a new class of anticancer drugs if researchers can solve the problem of how to deliver these fragile molecules to cancer cells.
Innovative drug treatment developed for familial adenomatous polyposis
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 3 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Psychologists